Jiangxi Fushine Pharmaceutical Co., Ltd. (SHE:300497)
16.38
+0.25 (1.55%)
At close: Feb 13, 2026
SHE:300497 Market Cap
SHE:300497 has a market cap or net worth of 8.82 billion as of February 13, 2026. Its market cap has increased by 105.26% in one year.
Market Cap
8.82B
Enterprise Value
9.93B
Revenue
970.32M
Ranking
n/a
PE Ratio
n/a
Stock Price
16.38
Market Cap Chart
Since December 22, 2015, SHE:300497's market cap has increased from 1.59B to 8.82B, an increase of 454.99%. That is a compound annual growth rate of 18.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 8.82B | 8.41% |
| Dec 31, 2025 | 8.14B | 81.18% |
| Dec 31, 2024 | 4.49B | -10.90% |
| Dec 29, 2023 | 5.04B | -29.09% |
| Dec 30, 2022 | 7.11B | -19.99% |
| Dec 31, 2021 | 8.89B | 34.93% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Youcare Pharmaceutical Group | 9.69B |
| Chengdu Kanghua Biological Products | 9.23B |
| Daan Gene | 9.02B |
| Sino Biological,Inc. | 9.00B |
| Shanghai Medicilon | 8.81B |
| Anhui Huaheng Biotechnology | 8.81B |
| Nanjing Vazyme Biotech | 8.38B |
| Acrobiosystems | 8.37B |